Tomás Harrington

Tomás Harrington
University of East Anglia | UEA · Norwich Business School

BSc (Hons) PhD MBA

About

31
Publications
16,847
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
608
Citations
Additional affiliations
March 2009 - March 2016
University of Cambridge
Position
  • Senior Researcher

Publications

Publications (31)
Article
This paper explores the characteristics of redistributed manufacturing systems within the context of emerging industry supply networks (EI SNs), with a particular focus on their structure, operations and reconfiguration dynamics. A number of factors have resulted in the redistribution of manufacturing. Within Emerging Industries, advances in proces...
Article
Full-text available
Targeting a series of advanced manufacturing technology (AMT) ‘interventions’ provides the potential for significant step changes across the pharmaceutical value chain, from early stage ‘system discovery’ and clinical trials, through to novel service supply models. This research explores future value network configurations which, when aligned with...
Article
Full-text available
This study presents a novel approach to designing and evaluating ‘last-mile’ solutions – encompassing the social and economic perspectives of key stakeholders. While urban system initiatives have been implemented in practice, theoretical gaps remain at the operational design level. A theoretical framework is developed, based on design criteria iden...
Article
Full-text available
Networked service organisations are increasingly adopting a ‘smarter networking’ philosophy in their design of more agile and customer-focused supply models. Changing consumer behaviours and the emergence of transformative technologies—industry 4.0, artificial intelligence, big data analytics, the Internet of Things—are driving a series of innovati...
Article
We draw from an eight-year dataset of 98 organisational entities involved in pre-competitive innovation networks across the UK pharmaceutical sector. These data map into three networks that are representative of: (i) a product development-led sequential pathway that begins with digitalised product development, followed by digitalisation of supply n...
Article
Full-text available
This research introduces the idea of ‘Circular Economy 4.0’ to reflect the emergence of ‘digitalised’ sustainable supply networks. While often characterised by enhanced productivity and resource/energy efficiency, current perspectives are largely descriptive with limited practical relevance. A hierarchical decision-making framework and a multi-leve...
Preprint
Full-text available
Since its launch just over a decade ago by the cryptocurrency Bitcoin, the distributed ledger technology (DLT) blockchain has followed a breathtaking trajectory into manifold application spaces. This study aper analyses how key factors underpinning the success of this ground-breaking “Internet of value” technology, such as staking of collateral (“s...
Article
There is an ongoing global shift in pharmaceutical business models from small molecule drugs to biologics. This increase in complexity is in response to advancements in our diagnoses and understanding of diseases. With the more targeted approach coupled with its inherently more costly development and manufacturing, 2D and 3D printing are being expl...
Article
Full-text available
We outline the concept of an open technology platform that builds upon a publicly accessible library of fluidic designs, manufacturing processes, and experimental characterization, as well as virtualization by a "digital twin" based on modeling, simulation, and cloud computing. Backed by the rapidly emerging Web3 technology "Blockchain," we signifi...
Article
Full-text available
An overwhelming majority of experts has been flagging for decades that "Saving the Planet" requires immediate, persistent and drastic action to curb a variety of catastrophic risks over the 21 st century. However, despite compelling evidence and a range of suggested solutions, transnational coordination of effective measures to protect our biospher...
Article
While ‘knowledge mobility’ presents significantly different challenges for SMEs and MNCs, it is strongly influenced by two common factors: the type of knowledge to be integrated and the configuration of the operations network. Here, SMEs and MNCs are required to make critical decisions about ‘levels’ of collaboration and knowledge sharing with netw...
Article
Full-text available
Continuous manufacturing is widely used for the production of commodity products. Currently, it is attracting increasing interest from the pharmaceutical industry and regulatory agencies as a means to provide a consistent supply of medicines. Crystallisation is a key operation in the isolation of the majority of pharmaceuticals and has been demonst...
Article
While ‘knowledge mobility’ presents significantly different challenges for SMEs and MNCs, it is strongly influenced by two common factors: the type of knowledge to be integrated and the configuration of the operations network. Only by understanding the various types of knowledge and how they - and the configuration profile of the network (Nascent,...
Article
Full-text available
Precision Medicine and Digital Health are emerging areas in healthcare, and they are underpinned by convergent or cross-industry innovation. However, convergence results in greater uncertainty and complexity in terms of technologies, value networks, and organization. There has been limited empirical research on emerging and convergent ecosystems, e...
Conference Paper
Full-text available
Generalisations or ‘rules of thumb’ are widely used in industry to make initial assessments on the sustainability impacts of products. This paper re-examines the principles underpinning these generalisations in assessing the environmental impacts of medicine manufacturing network configurations. Each principle is illustrated through the application...
Article
Full-text available
This research evaluates reconfiguration opportunities in Pharmaceutical Supply Chains (PSC) resulting from technology interventions in manufacturing, and new, more patient-centric delivery models. A critical synthesis of the academic and practice literature is used to identify, conceptualise, analyse and categorise PSC models. From a theoretical pe...
Article
This paper investigates environmental sustainability dynamics of an industrial system through a case study on the UK medical technology sector. This paper builds on an industrial system framework involving institutions, specialist firms, value/supply chains and industrial actors. Environmental sustainability dynamics are explored through infrastruc...
Article
This research explores different ‘modes’ of supply network emergence that may exist in the process of technology commercialisation, and examines how key actors and enterprises design and re-configure their emerging and existing networks. A generic ‘stages’ model to better understand supply network evolution - in the context of emerging technologies...
Article
Full-text available
2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis GroupTargeting a series of advanced manufacturing technology (AMT) ?interventions? provides the potential for significant step changes across the pharmaceutical value chain, from early stage ?system discovery? and clinical trials, through to novel service supply models...
Article
This research explores different ‘modes’ of supply network emergence that may exist in the process of technology commercialisation, and examines how key actors and enterprises design and re-configure their emerging and existing networks. A generic ‘stages’ model to better understand supply network evolution - in the context of emerging technologies...
Article
This is the author accepted manuscript. It is currently under an indefinite embargo pending publication of the final version.
Article
Global regulatory, manufacturing and consumer trends are driving a need for change in current pharmaceutical sector business models, with a specific focus on the inherently expensive research costs, high-risk capital-intensive scale-up and the traditional centralised batch manufacturing paradigm. New technologies, such as inkjet printing, are being...
Article
Full-text available
Many manufacturing firms have developed a service dimension to their product portfolio. In response to this growing trend of servitisation, organisations, often involved in complex, long-lifecycle product-service system (PSS) provision, need to reconfigure their global engineering networks to support integrated PSS offerings. Drawing on parallel co...
Article
Full-text available
The effect of globalisation such as borderless markets, increasing competition, rapidly improving technology and changing customer requirements has changed the nature of original equipment manufacturers. As equipment provision has become more complex and competition heightened, firms have felt the pressure to add value, predominantly through the pr...

Projects

Project (1)
Project
This project encompasses most of my research activity at IfM Cambridge, which are mainly related to the ReMediES project (https://remediesproject.com/)